unknown
Stage
1
Investors
About
Bioherent develops advanced biosensor technology combining silicon photonics and nanomaterials to provide accurate, fast, and accessible in vitro diagnostics for drug allergy detection and research applications.
Explore Bioherent's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.